- Home
- NBP vs CNDT Comparison
NBP vs CNDT Comparison
Compare NBP & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBP | CNDT |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | United States |
| Employees | 30 | 51000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.5M | 201.6M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NBP | CNDT |
|---|---|---|
| Price | $2.12 | $1.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | 698.9K | ★ 1.2M |
| Earning Date | 04-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,042,000,000.00 |
| Revenue This Year | N/A | $2.01 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.46 | $1.15 |
| 52 Week High | $5.19 | $2.98 |
Technical Indicators
Market Signals| Indicator | NBP | CNDT |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 53.85 |
| Support Level | $2.10 | $1.32 |
| Resistance Level | $2.73 | $1.60 |
| Average True Range (ATR) | 0.15 | 0.10 |
| MACD | 0.09 | 0.02 |
| Stochastic Oscillator | 83.98 | 71.86 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.